PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-02-15

Date Title Company
15-Feb-2024 Firefly Bio Debuts With $94 Million Series A Financing Businesswire
15-Feb-2024 Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer Businesswire
15-Feb-2024 Travel Nurses, Inc. Named Top-Rated Healthcare Agency AccessWire
15-Feb-2024 Selkirk Pharma Announces New APS Qualified Facility with Advanced Fill/Finish Capacity in Spokane, WA Businesswire
15-Feb-2024 Areteia Therapeutics Announces Appointment of Daniel Becker, M.D., Ph.D. To Board of Directors Businesswire
15-Feb-2024 New Vitality Study Reveals: Employers Reduced Claims Costs by 4% and Achieved ROI of 180% from Claims Savings on Health and Wellbeing Program Businesswire
15-Feb-2024 SkyWater Signs Production Agreement with Nautilus Biotechnology to Fabricate Novel Biomedical Devices Businesswire
15-Feb-2024 Forecasting the Future of Cryo Boxes: Analyzing Market Dynamics and Growth Factors Amidst Technological Advancements MARKITWIRED
15-Feb-2024 Quince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors Businesswire
15-Feb-2024 Pasadena Villa Outpatient Opens Mental Health Clinic in Tampa, Florida AccessWire
15-Feb-2024 KalVista Pharmaceuticals Announces Pricing of a $160.1 Million Public Offering of Common Stock and Pre-Funded Warrants Businesswire
15-Feb-2024 Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering AccessWire
15-Feb-2024 Adial Pharmaceuticals to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20 AccessWire
15-Feb-2024 Revolutionizing Veteran Care: Get Well Unveils Breakthrough Outcomes in Veterans Health Administration (VHA) Collaboration AccessWire
15-Feb-2024 Jaguar Health Announces FDA Agrees with Clinical Trial Protocol for Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs AccessWire
15-Feb-2024 Enalare Therapeutics Announces Publication of a Clinical Study Demonstrating the Effect of ENA-001 on Improving Propofol-Induced Depression of the Hypoxic Ventilatory Response Newswire
15-Feb-2024 Enalare Therapeutics Announces Publication of a Clinical Study Demonstrating the Effect of ENA-001 on Improving Propofol-Induced Depression of the Hypoxic Ventilatory Response AccessWire
15-Feb-2024 Tonix Drug Shown To Relieve Pain in Fibromyalgia Without Risk of Addiction AccessWire
15-Feb-2024 Ensysce Biosciences Announces Publication of Clinical Bioequivalence Manuscript AccessWire
15-Feb-2024 Lexaria Announces $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules AccessWire